查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1983143

糖生物学市场：按产品类型、应用、最终用户和地区划分

Glycobiology Market, By Product Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

糖生物学市场预计在 2026 年达到 22 亿美元，预计到 2033 年将达到 74.8 亿美元。预计从 2026 年到 2033 年，其复合年增长率将达到 19.1%。

报告范围 报告详情
基准年： 2025 2026年市场规模： 22亿美元
目标期限： 2020年至2024年 预测期： 2026年至2033年
2026年至2033年预测期间的复合年增长率： 19.10% 2033年市场规模预测： 74.8亿美元

醣生物学是研究聚醣和糖基化生物分子（统称为糖分子，包括醣脂、糖蛋白和糖化小分子）的科学分支。聚醣普遍存在于生命体的各个面向。碳水化合物结构与脂质、蛋白质、代谢物和核酸等生物分子的结合，会对其理化性质、细胞内分布形态、免疫抗原性以及药物动力学和动态产生显着影响。

所有细胞以及许多蛋白质（例如糖蛋白）表面都覆盖着密集而复杂的共用连接的糖链序列（称为寡糖或聚醣）。这些聚醣的生物学功能在复杂的细胞器和生物体的形成中特别重要，这些细胞器和生物体需要细胞间以及与周围细胞外基质的相互作用。大多数类型的聚醣存在于细胞表面或分泌的大分子中。此外，在细胞核和细胞质中也存在大量代谢迅速的简单蛋白质结合聚醣，它们在那里发挥调节开关的作用。

聚醣是一种种类繁多且结构复杂的分子，其功能取决于其独特的结构。阐明聚醣结构需要有效的酶学工具和分析技术，这些工具和技术与特定的功能相关。聚醣修饰决定了蛋白质和细胞的黏附特性。免疫系统主要透过聚醣与蛋白质的相互作用发挥作用，凸显了聚醣在生理、病原体识别、癌症和自体免疫疾病中的重要性。

市场动态

糖生物学市场成长的关键驱动因素包括非内部成长策略的采用，例如市场主要企业的收购。例如，2018年6月，美国生命科学公司安捷伦科技收购了ProZyme Inc.，后者是私人公司。此次收购将使安捷伦科技能够扩展其糖生物学产品组合。

本次调查的主要特点

  • 本报告对全球糖生物学市场进行了详细分析，以 2021 年为基准年，给出了预测期（2022-2030 年）的市场规模和复合年增长率。
  • 此外，它还指出了每个细分市场的潜在商机，并说明了该市场中一个有吸引力的投资提案矩阵。
  • 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
  • 本报告根据以下参数对全球糖生物学市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
  • 透过利用本报告中提出的见解，企业行销负责人和经营团队将能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
  • 本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 透过分析全球糖生物学市场中使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。

目录

第一章：研究目标与前提条件

  • 研究目标
  • 前提
  • 简称

第二章 市场概览

  • 报告摘要
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、监管与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特的分析
  • 市场机会
  • 法规环境
  • 主要进展
  • 产业趋势

第四章 全球糖生物学市场：依产品类型划分，2020-2033年

  • 装置
  • 酵素
  • 糖苷酶
  • GlcNAc转移酶
  • GalNAc转移酶
  • 消耗品
  • 试剂和试剂盒

第五章 全球糖生物学市场：依应用领域划分，2020-2033年

  • 诊断用途
  • 工业应用
  • 治疗用途
  • 药物发现与开发
  • 其他的

第六章 全球糖生物学市场：依最终用户划分，2020-2033年

  • 研究机构
  • 医院
  • 诊断中心
  • 生物製药公司
  • 其他的
  • 食物

第七章 全球糖生物学市场：依地区划分，2020-2033年

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第八章 竞争情势

  • Tracxn Technologies Limited
  • Agilent Tecnologies, Inc
  • Blirt.eu
  • Takara Bio Inc.
  • Bio-Techne
  • Bruker Corporation
  • Thermo Fisher Scientific Inc
  • Shimadzu Corporation
  • New England Biolabs.
  • Waters.co.
  • Merck KGaA
  • Palleon Pharmaceuticals
  • Asparia Glycomics
  • RayBiotech Life, Inc
  • Z Biotech, LLC
  • Chemily Glycoscience
  • Lectenz Bio,
  • 2BScientific
  • Glycodiag

第九章 分析师建议

  • 机会
  • 分析师意见
  • Coherent Opportunity Map

第十章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于本公司
简介目录
Product Code: CMI3639

Glycobiology Market is estimated to be valued at USD 2.2 Bn in 2026 and is expected to reach USD 7.48 Bn by 2033, growing at a compound annual growth rate (CAGR) of 19.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.2 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 19.10% 2033 Value Projection: USD 7.48 Bn

Glycobiology is the branch of science which deals with the study of Glycan and glycan-modified biomolecules such as glycolipids, glycoproteins and glycosylated small molecules collectively referred to as sugar molecules. Glycan are universal in all aspects of life. The binding of carbohydrate structures to biomolecules, including lipids, proteins, metabolites, and nucleic acids, can profoundly affect their physicochemical properties, subcellular localization, immunogenicity, and pharmacokinetics and pharmacodynamics.

All cells and many proteins such as glycoproteins are covered with dense and complex arrays of covalently linked sugar chains (called oligosaccharides or glycan). The biological roles of these glycan are of particular importance in the assembly of complex multicellular organs and organisms, processes that require interactions between cells and with the surrounding extracellular matrix. Most classes of glycan are found on the surface of cells and secreted macromolecules. In addition, simple, rapidly metabolizing protein-bound glycan are abundant in the nucleus and cytoplasm, where they function as regulatory switches.

Glycan are diverse and complex molecules whose functions are determined by their unique structures. Glycan structures requires effective enzymatic tools and analytical techniques and can be associated with specific functions. Glycosylation defines the adhesive properties of proteins and cells. The immune system functions primarily through carbohydrate-protein interactions, highlighting the importance of carbohydrates in physiology, pathogen recognition, cancer, and autoimmune diseases.

Market Dynamics

Major factors driving growth of the glycobiology market include adoption of inorganic growth strategies such as acquisitions by key players in the market. For instance, in June, 2018, Agilent Technologies, an American life science company, has acquired privately held ProZyme Inc., a provider of glycan analysis, reagents and kits. This acquisition will help the company expand its glycobiology product portfolio

Key features of the study

  • This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global glycobiology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Tracxn Technologies Limited, Agilent Tecnologies,Inc., Blirt.eu, Takara Bio Inc., Bio-Techne, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, New England Biolabs., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific , and Glycodiag
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2026 - 2033)
    • Instruments
    • Enzymes
    • Glycosidase
    • Heparinase
    • Chitinase
    • Acetylgalactosaminidase
    • PNGase
    • Chitobiase
    • Others (Hyaluronidase , Hexosaminidase)
    • GlcNAc Transferases
    • Acetylglucosaminyltransferase
    • Exostosin
    • Others (GD2 Synthase,B3GANLT)
    • GalNAc Transferases
    • Polypeptide GalNAc Transferase
    • GANLTL
    • Others
    • Fucosyl Transferases
    • Galactosyl Transferases
    • Carbohydrate Kinases
    • Others
    • Consumables
    • Reagents & Kits
  • Application Insights (Revenue, USD Bn, 2026 - 2033)
    • Diagnostic Application
    • Industrial Application
    • Therapeutic Application
    • Drug Discovery and Development
    • Others
  • End User Insights (Revenue, USD Bn, 2026 - 2033)
    • Research Laboratories
    • Hospitals
    • Diagnostic Centres
    • Biopharmaceutical Companies
    • Others
    • Food
  • Regional Insights (Revenue, USD Bn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Key Players Insights
    • Tracxn Technologies Limited
    • Agilent Tecnologies, Inc
    • Blirt.eu
    • Takara Bio Inc.
    • Bio-Techne
    • Bruker Corporation
    • Thermo Fisher Scientific Inc
    • Shimadzu Corporation
    • New England Biolabs.
    • Waters.co.
    • Merck KGaA
    • Palleon Pharmaceuticals
    • Asparia Glycomics
    • RayBiotech Life, Inc
    • Z Biotech, LLC
    • Chemily Glycoscience
    • Lectenz Bio,
    • 2BScientific
    • Glycodiag

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Glycobiology Market, By Product Type
    • Global Glycobiology Market, By Application
    • Global Glycobiology Market, By End User
    • Global Glycobiology Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Glycobiology Market, By Product Type, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
    • Segment Trends
  • Glycosidase
    • Heparinase
    • Chitinase
    • Acetylgalactosaminidase
    • PNGase
    • Chitobiase
    • Others
  • GlcNAc Transferases
    • Acetylglucosaminyltransferase
    • Exostosin
    • Others
  • GalNAc Transferases
    • Polypeptide GalNAc Transferase
    • GANLTL
    • Others
      • Fucosyl Transferases
      • Galactosyl Transferases
      • Carbohydrate Kinases
      • Others
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Reagents & Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Glycobiology Market, By Application, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostic Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Industrial Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Therapeutic Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Glycobiology Market, By End User, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Diagnostic Centres
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Food
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Global Glycobiology Market, By Region, 2020 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Tracxn Technologies Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Tecnologies, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Blirt.eu
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bruker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Waters.co.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Palleon Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Asparia Glycomics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RayBiotech Life, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Z Biotech, LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chemily Glycoscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lectenz Bio,
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 2BScientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glycodiag
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us